JPMorgan Chase & Co’s Harmony Biosciences HRMY Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | $6.13M | Sell |  | |||||
| 2025 Q1 | $16.1M | Buy |  | |||||
| 2024 Q4 | $8.12M | Buy |  | |||||
| 2024 Q3 | $9.22M | Buy |  | |||||
| 2024 Q2 | $4.13M | Buy |  | |||||
| 2024 Q1 | $1.44M | Sell |  | |||||
| 2023 Q4 | $3.97M | Buy |  | |||||
| 2023 Q3 | $2.58M | Sell |  | |||||
| 2023 Q2 | $3.63M | Buy |  | |||||
| 2023 Q1 | $1.77M | Sell |  | |||||
| 2022 Q4 | $5.11M | Sell |  | |||||
| 2022 Q3 | $5.15M | Buy |  | |||||
| 2022 Q2 | $4.73M | Buy |  | |||||
| 2022 Q1 | $1.23M | Buy |  | |||||
| 2021 Q4 | $953K | Buy |  | |||||
| 2021 Q3 | $365K | Sell |  | |||||
| 2021 Q2 | $285K | Sell |  | |||||
| 2021 Q1 | $565K | Sell |  | |||||
| 2020 Q4 | $704K | Buy |  | |||||
| 2020 Q3 | $12K | Buy |  | 
